Ganglionic activity of 1-(2-bromophenyl)-3-(trimethyl-ammonium)-1-propene bromide (S-11-127).
D000315:Adrenalectomy; D000475:Alkenes / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002714:Chlorisondamine / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects; D005731:Ganglionic Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D011312:Pressure; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D001743:Urinary Bladder / Q000187:drug effects / Q000502:physiology
D000475:Alkenes; D005731:Ganglionic Stimulants; D000644:Quaternary Ammonium Compounds; C000670:S-11-127; D004246:Dimethylphenylpiperazinium Iodide; D002714:Chlorisondamine